Nektar Therapeutics
Open
68.93 -0.2
Overview
Share price change
24h
Min
68.26
Max
69.74
Income | -8.8M -45M |
|---|---|
Sales | -11M 11M |
EPS | -1.783 |
Profit margin | -413.443 |
Employees | 63 |
EBITDA | -19M -38M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +127.45% upside |
Next Earnings | 6 sie 2026 |
|---|
Market Cap | -620M 2.3B |
|---|---|
Previous open | 69.13 |
Previous close | 68.93 |
Technical Score
By Trading Central
Confidence
Strong Bearish Evidence
Nektar Therapeutics Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
12 Months Forecast
Average 153.71 USD 127.45%
High 192 USD
Low 80 USD
Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$